loadpatents
name:-0.025584936141968
name:-0.021094083786011
name:-0.01589298248291
Diem; Michael Patent Filings

Diem; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Diem; Michael.The latest application filed is for "cd137 binding fibronectin type iii domains".

Company Profile
14.19.23
  • Diem; Michael - Havertown PA
  • Diem; Michael - Spring House PA
  • Diem; Michael - Radnor PA US
  • Diem; Michael - Orange CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
PD-L1 binding fibronectin type III domains
Grant 11,447,539 - Diem , et al. September 20, 2
2022-09-20
Cd137 Binding Fibronectin Type Iii Domains
App 20220259289 - Diem; Michael ;   et al.
2022-08-18
CD137 binding fibronectin type III domains
Grant 11,345,739 - Diem , et al. May 31, 2
2022-05-31
Serum Albumin-Binding Fibronectin Type III Domains
App 20210228688 - Diem; Michael ;   et al.
2021-07-29
EGFR and C-Met Fibronectin Type III Domain Binding Molecules
App 20210206825 - Anderson; Mark ;   et al.
2021-07-08
Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains
App 20210147510 - Cardoso; Rosa ;   et al.
2021-05-20
EGFR and c-Met fibronectin type III domain binding molecules
Grant 10,954,284 - Anderson , et al. March 23, 2
2021-03-23
Serum albumin-binding fibronectin type III domains
Grant 10,925,932 - Diem , et al. February 23, 2
2021-02-23
Materials And Methods For Improved Single Chain Variable Fragments
App 20210047435 - Luo; Jinquan ;   et al.
2021-02-18
CD137 Binding Fibronectin Type III Domains
App 20210040180 - Diem; Michael ;   et al.
2021-02-11
Pd-l1 Binding Fibronectin Type Iii Domains
App 20210024612 - Diem; Michael ;   et al.
2021-01-28
Prostate specific membrane antigen binding fibronectin type III domains
Grant 10,844,111 - Cardoso , et al. November 24, 2
2020-11-24
Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
Grant 10,844,122 - Anderson , et al. November 24, 2
2020-11-24
Cysteine Engineered Fibronectin Type Iii Domain Binding Molecules
App 20200325210 - Anderson; Mark ;   et al.
2020-10-15
Cysteine engineered fibronectin type III domain binding molecules
Grant 10,662,235 - Anderson , et al.
2020-05-26
CD137 binding fibronectin type III domains
Grant 10,611,823 - Diem , et al.
2020-04-07
PD-L1 binding fibronectin type III domains
Grant 10,597,438 - Diem , et al.
2020-03-24
Fibronectin type III repeat based protein scaffolds with alternative binding surfaces
Grant 10,571,472 - Diem , et al. Feb
2020-02-25
Anti-cd33 Antibodies, Anti-cd33/anti-cd3 Bispecific Antibodies And Uses Thereof
App 20190382481 - Diem; Michael ;   et al.
2019-12-19
PD-L1 Binding Fibronectin Type III Domains
App 20180162928 - Diem; Michael ;   et al.
2018-06-14
CD137 Binding Fibronectin Type III Domains
App 20180162929 - Diem; Michael ;   et al.
2018-06-14
Fibronectin Type III Repeat Based Protein Scaffolds with Alternative Binding Surfaces
App 20180143203 - Diem; Michael ;   et al.
2018-05-24
Fibronectin type III repeat based protein scaffolds with alternative binding surfaces
Grant 9,897,612 - Diem , et al. February 20, 2
2018-02-20
Cysteine Engineered Fibronectin Type III Domain Binding Molecules
App 20170362301 - Anderson; Mark ;   et al.
2017-12-21
Serum Albumin-Binding Fibronectin Type III Domains
App 20170348397 - Diem; Michael ;   et al.
2017-12-07
EGFR and C-Met Fibronectin Type III Domain Binding Molecules
App 20170305997 - Anderson; Mark ;   et al.
2017-10-26
EGFR and C-Met fibronectin type III domain binding molecules
Grant 9,725,497 - Anderson , et al. August 8, 2
2017-08-08
EGFR and c-Met fibronectin type III domain binding molecules
Grant 9,695,228 - Mark , et al. July 4, 2
2017-07-04
Prostate Specific Membrane Antigen (PSMA) Bispecific Binding Agents and Uses Thereof
App 20160347840 - Anderson; Glenn ;   et al.
2016-12-01
Prostate Specific Membrane Antigen Binding Fibronectin Type III Domains
App 20160326232 - Rosa; Cardosa ;   et al.
2016-11-10
Fibronectin Type III Repeat Based Protein Scaffolds with Alternative Binding Surfaces
App 20160041182 - Diem; Michael ;   et al.
2016-02-11
Fibronectin type III repeat based protein scaffolds with alternative binding surfaces
Grant 9,200,273 - Diem , et al. December 1, 2
2015-12-01
Egfr And C-met Fibronectin Type Iii Domain Binding Molecules
App 20140155325 - Mark; Anderson ;   et al.
2014-06-05
Egfr And C-met Fibronectin Type Iii Domain Binding Molecules
App 20140155326 - Mark; Anderson ;   et al.
2014-06-05
Insulin-like growth factor 1 receptor binding peptides
Grant 8,415,306 - Diem , et al. April 9, 2
2013-04-09
Fibronectin Type III Repeat Based Protein Scaffolds with Alternative Binding Surfaces
App 20130079243 - Diem; Michael ;   et al.
2013-03-28
Insulin-like growth factor 1 receptor binding peptides
App 20110294748 - Diem; Michael ;   et al.
2011-12-01
Process and apparatus for low pressure chemical vapor deposition of refractory metal
Grant 4,817,557 - Diem , et al. April 4, 1
1989-04-04
Process for low pressure chemical vapor deposition of refractory metal
Grant 4,726,961 - Diem , et al. February 23, 1
1988-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed